SYNERGEYES INC

CARLSBAD, CA · Medtech · Acquired

Hybrid contact lenses combining rigid and soft materials for astigmatism, presbyopia, and keratoconus correction

Claim this profile

Follows are private to you and power your alerts

Updated · synergeyes.com

Sector
Medtech
Headquarters
CARLSBAD, CA
Latest Form D
$3.5M, Feb 2017
Total capital
$5.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$5.5M
2 Form D · last Feb 2017
117 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
9 pending · first 2017
Rank in peer group#498 of 1112

Capital timeline

201520162017FEDERAL ↑EQUITY ↓Cumulative $5.5M1st Form D$2M2nd Form D$3.5M
201520162017FEDERAL ↑EQUITY ↓Cumulative $5.5M1st Form D$2M2nd Form D$3.5M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$3.5M
  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#498 · top 45%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Carolyn K. MaduzaExecutive OfficerNamed in SEC Form D filings
  • David K. MichaelDirectorNamed in SEC Form D filings
  • James K. BerglundDirectorNamed in SEC Form D filings
  • James K. Berglund, Ph.D.DirectorNamed in SEC Form D filings
  • James K. BochnowskiDirectorNamed in SEC Form D filings
  • James K. Kirchner, O.D.Executive Officer, DirectorNamed in SEC Form D filings
Show all 10 people
  • Jay K. WatkinsDirectorNamed in SEC Form D filings
  • Nick K. BrownExecutive OfficerNamed in SEC Form D filings
  • Renee K. MasiDirectorNamed in SEC Form D filings
  • Steve K. FanningDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 10
  • PendingHybrid Contact LensUSPTOApplication 15488312
  • GrantedHybrid Contact LensUSPTOUS 9,625,738
  • PendingHybrid Contact LensUSPTOApplication 61934671
Show all 10 patent records
  • Hybrid Contact LensNov 16, 2017 · Application 15488312Pending
  • Hybrid Contact LensApr 18, 2017 · US 9,625,738Granted
  • Hybrid Contact LensApplication 61934671Pending
  • Methods For Improving The Hydrophilicity Of Contact Lenses And Contact Lenses Having The SameApplication PCTUS2006040610Pending
  • Hybrid Contact Lens System And Method Of FittingApplication PCTUS2006039121Pending
  • Hybrid Contact Lens System And Method Of FittingApplication PCTUS2006014950Pending
  • Method And Apparatus For Reducing Or Eliminating The Progression Of MyopiaApplication PCTUS2006012868Pending
  • Multipurpose Optical Imaging Device, System And MethodeApplication PCTUS2005030969Pending
  • Hybrid Contact Lens System And MethodApplication PCTUS2005004368Pending
  • Hybrid Contact LensApplication PCTUS2015012308Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .